Latest News about Virpax Pharmaceuticals Inc/
Recent news which mentions Virpax Pharmaceuticals Inc/
Lab Notes: AnPac dips into real estate with diversification strategy; Mineralys closes $220.8M IPO
February 17, 2023
Tickers
INNO
From Business Journals
Tickers
INNO
From Business Journals
Lab Notes: Endo acquires 6 product candidates for $35M; NiKang signs deal worth up to $218M
May 06, 2022
Tickers
INNO
From Business Journals
Lab Notes: Helius launches flagship product in U.S.; Virpax reports positive preclinical results for seizure drug
April 29, 2022
Tickers
INNO
From Business Journals
From Business Journals
Lab Notes: LIMR awarded research grant; Virpax posts positive study results for pain treatment
January 21, 2022
Tickers
INNO
From Business Journals
Lab Notes: Lannett files FDA application for new drug; Virpax to start clinical trial for knee pain drug candidate
December 23, 2021
Tickers
INNO
From Business Journals
Lab Notes: Arbutus and Penn make headway on Covid-19 treatments; Carisma partners with Merck
December 10, 2021
Tickers
INNO
From Business Journals
Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and more
September 24, 2021
Tickers
INNO
From Business Journals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.